AI in Pharma
Bristol Myers Squibb Powers Next-Gen Drug Discovery with Nvidia AI System
Bristol Myers Squibb (BMS) is making a significant leap in pharmaceutical innovation by acquiring Nvidia's state-of-the-art AI computing system, a move poised to revolutionize its drug discovery and development processes. This strategic investment underscores the growing recognition within the life sciences sector of artificial intelligence's transformative